Antibiotice (BSE:ATB) Short Interest


BSE:ATB Antibiotice SA BSE:ATB
75 GF Score
Price lei2.12
GF Value lei2.19
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Antibiotice Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BSE:ATB vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Antibiotice Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Short Interest distribution charts can be found below:

* The bar in red indicates where Antibiotice's Short Interest falls into.


BSE:ATB
75GF Score
Antibiotice SA BSE:ATB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Antibiotice (BSE:ATB) Overvalued in 2026?

Based on GuruFocus' analysis, Antibiotice stock appears to be undervalued. The current stock price of lei2.12 is trading 3.4% below its estimated GF Value™ of lei2.19. GuruFocus considers Antibiotice to be Fairly Valued.

Key valuation signals for BSE:ATB:

  • Short Interest:
  • GF Value™: lei2.19 vs. price of lei2.12 (3.4% below fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the BSE:ATB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Antibiotice Business Description

Address 1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice SA is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).
75GF Score

Get the complete analysis for BSE:ATB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei2.12
Price
lei2.19
GF Value